KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$0.21.

  • Fulgent Genetics' EPS (Basic) rose 5625.0% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.39, marking a year-over-year increase of 7481.88%. This contributed to the annual value of -$1.41 for FY2024, which is 7495.56% up from last year.
  • Fulgent Genetics' EPS (Basic) amounted to -$0.21 in Q3 2025, which was up 5625.0% from -$0.62 recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' EPS (Basic) peaked at $6.96 during Q1 2021, and registered a low of -$4.3 during Q4 2023.
  • In the last 5 years, Fulgent Genetics' EPS (Basic) had a median value of -$0.29 in 2024 and averaged $0.73.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 783333.33% in 2021, then tumbled by 83333.33% in 2023.
  • Fulgent Genetics' EPS (Basic) (Quarter) stood at $3.53 in 2021, then crashed by 122.69% to -$0.8 in 2022, then plummeted by 437.54% to -$4.3 in 2023, then skyrocketed by 95.58% to -$0.19 in 2024, then fell by 10.53% to -$0.21 in 2025.
  • Its EPS (Basic) stands at -$0.21 for Q3 2025, versus -$0.62 for Q2 2025 and -$0.37 for Q1 2025.